• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Mammotest boosts Fischer’s 1999 results

Article

X-ray and mammography vendor Fischer Imaging posted revenue increases for the fourth quarter and year (end-December), thanks to growth in its Mammotest stereotactic biopsy business and the restructuring of its operations last September. Mammotest sales

X-ray and mammography vendor Fischer Imaging posted revenue increases for the fourth quarter and year (end-December), thanks to growth in its Mammotest stereotactic biopsy business and the restructuring of its operations last September. Mammotest sales increased both in the U.S., through Fischer’s direct sales force, and in Europe, through its partnership with Johnson & Johnson’s Ethicon Endo-Surgery division (SCAN 10/29/97).

The company reported fourth quarter revenues of $16.3 million, up 9% from $15 million in the same period 1998, and net income of $398,000, compared to a net loss of $4.4 million in 1998. For the year, Denver-based Fischer’s revenues climbed 10%, from 1998’s $59.8 million to $66 million. Net loss for the year was $343,000, compared to a loss of $6.8 million in 1998.

Also during the fourth quarter, Fischer moved closer to filing a regulatory approval application with the Food and Drug Administration for its full-field digital mammography unit, SenoScan. The company has been in discussions with the FDA, according to Morgan Nields, chairman and CEO, and is in the process of evaluating whether to submit a 510(k) or a PMA.

Related Videos
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.